Karolinska Development
 

View full portfolio and sort by:

   

Solid colored area = completed phase                  Shaded colored area = ongoing phase

 

Oncology Concept Development Lead Discovery Lead Optimization Preclinical Development Phase I Phase II Phase III Launch

Axelar AB

KDev Oncology AB (AKN-028)

Aprea AB

Oncopeptides AB

KDev Oncology AB (GliGene)
Dermatology and Wound Healing Concept Development Lead Discovery Lead Optimization Preclinical Development Phase I Phase II Phase III Launch

Pergamum AB (DPK-060, atopic dermatitis)

Pergamum AB (PXL01)

Pergamum AB (DPK-060, external otitis)

Pergamum AB (LL-37)
Women's Health Concept Development Lead Discovery Lead Optimization Preclinical Development Phase I Phase II Phase III Launch

Dilafor AB

Umecrine Mood AB

Pharmanest AB

Infectious Disease Concept Development Lead Discovery Lead Optimization Preclinical Development Phase I Phase II Phase III Launch

Dilaforette AB

Biosergen AS

Cardiovascular Concept Development Lead Discovery Lead Optimization Preclinical Development Phase I Phase II Phase III Launch

Athera Biotechnologies AB (Annexin A5)

Athera Biotechnologies AB (PC-mAb)
Inflammation Concept Development Lead Discovery Lead Optimization Preclinical Development Phase I Phase II Phase III Launch

NovaSAID AB

ProNoxis AB

Ophthalmology Concept Development Lead Discovery Lead Optimization Preclinical Development Phase I Phase II Phase III Launch

Clanotech AB

CNS Concept Development Lead Discovery Lead Optimization Preclinical Development Phase I Phase II Phase III Launch

BioChromix Pharma AB

Umecrine Cognition AB

Technology Concept Development Prototype Development Product Sales

Promimic AB

XSpray Microparticles AB

Inhalation Sciences Sweden AB

NeoDynamics AB (Fourier/AS)

NeoDynamics AB ((Therapy/PRFA) Anti-Meta)

Oss-Q AB

Lipidor AB

Theranostics Concept Development Prototype Development Product Sales

Athera Biotechnologies AB (lgM anti-PC (CVDefine kit))

BioChromix AB

Financial/Passive Investments

Pharmaceutical Concept Development Lead Discovery Lead Optimization Preclinical Development Phase I Phase II Phase III Launch

Pergamum AB (Laurantis Pharma Oy) (cis-UCA dermatology)

NephroGenex Inc.

BioArctic Neuroscience AB

Pergamum AB (Laurantis Pharma Oy) (cis-UCA oncology)

Pergamum AB (Laurantis Pharma Oy) (ad-VEGF-C)

CytoGuide ApS